524663 — Bharat Immunologicals and Biologicals Share News
0.000.00%
HealthcareSpeculativeMicro Cap
- IN₹400.28m
- IN₹1.06bn
- IN₹446.09m
EU proposes booster jabs for 2022 travel, opens to WHO vaccines (updated)
Refinitiv Newscasts - Asia Insight: India plans refiners' joint oil deals to cut import bill
Brazil police raid pharmaceutical firm amid Senate vaccine probe
Media: Bharat Bio begins first phase of human trials of Covaxin - Economic Times
Brief: India's Bharat Immunologicals and Biologicals Corp March-qtr profit surges
Brief: Bharat Immunologicals & Biologicals Corp posts Dec-qtr profit
Brief: Bharat Immunologicals and Biologicals posts Sept qtr profit
Brief: Bharat Immunologicals and Biologicals June-qtr loss narrows